BackNOV Overview
NOV Inc

NOV Target Price

Analysts' average 12-month price target for NOV is $23.

Get informed when a big investor buys or sells

+ Follow

Share Price

$18.8

Average Target Price

$23.0022.3% upside

3 analysts in the last 4 months

High: $26 | Low: $21

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15Morgan Stanley$2111.7% upsideOpen
2026-07-08Susquehanna$2217% upsideOpen
2026-06-04Capital One Financial$2638.3% upsideOpen
2026-06-03Goldman Sachs$191.1% upsideOpen
2026-05-07BarclaysDavid Anderson$2111.7% upsideOpen
2026-04-29Susquehanna$2427.7% upsideOpen
2026-04-15Morgan Stanley$206.4% upsideOpen
2026-02-09Piper SandlerDerek Podhaizer$184.3% downsideOpen
2026-02-06Evercore ISIJason Bandel$191.1% upsideOpen
2026-02-06Stifel Nicolaus$2111.7% upsideOpen
2026-02-06Susquehanna$2111.7% upsideOpen
2026-01-15RBC CapitalKeith Mackey$2111.7% upsideOpen
2026-01-14Goldman Sachs$179.6% downsideOpen
2026-01-07SusquehannaCharles Minervino$206.4% upsideOpen
2025-12-18Piper SandlerDerek Podhaizer$179.6% downsideOpen
2025-12-17Barclays$1520.2% downsideOpen
2025-12-15Morgan StanleyJoe Laetsch$1614.9% downsideOpen
2025-11-11BarclaysDavid Anderson$1330.9% downsideOpen
2025-11-05Goldman SachsAti Modak$1425.5% downsideOpen
2025-10-30Barclays$1425.5% downsideOpen
2025-10-29Stifel Nicolaus$191.1% upsideOpen
2025-10-29RBC Capital$191.1% upsideOpen
2025-10-28Raymond JamesJames Rollyson$179.6% downsideOpen
2025-07-30Susquehanna$179.6% downsideOpen
2025-04-15Stifel NicolausStephen Gengaro$2322.3% upsideOpen
2025-03-24RBC CapitalKeith Mackey$2217% upsideOpen
2024-12-18BarclaysDavid Anderson$1236.2% downsideOpen
2024-10-11Stifel NicolausStephen Gengaro$2533% upsideOpen
2024-10-10BMO CapitalPhillip Jungwirth$206.4% upsideOpen
2024-09-16Morgan StanleyDaniel Kutz$2322.3% upsideOpen
2024-07-30BarclaysDavid Anderson$206.4% upsideOpen
2023-02-08Susquehanna$2954.3% upsideOpen
2022-07-29Morgan Stanley$191.1% upsideOpen
2022-07-13Morgan Stanley$184.3% downsideOpen
2022-07-13Goldman Sachs$1614.9% downsideOpen
2022-06-08Barclays$2217% upsideOpen
2022-05-02Barclays$206.4% upsideOpen
2022-02-04Evercore ISIJames West$2217% upsideOpen
2021-12-09Cowen & Co.Marc Bianchi$191.1% upsideOpen
2021-10-11Morgan StanleyConnor Lynagh$179.6% downsideOpen
2021-07-19BMO CapitalPhillip Jungwirth$1520.2% downsideOpen
2021-05-04Coker PalmerVaibhav Vaishnav$1236.2% downsideOpen

NOV (NOV) FAQ

NOV (NOV) currently reports a target price of $23. Use the charts on this page to explore NOV's target price history and peer comparisons.

Analysts' average 12-month price target for NOV is $23, about 22.3% upside from the current share price of $18.8. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $23, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NOV, and consider following NOV for alerts when major investors trade the stock.

NOV is classified in the Industrials sector. On target price, it currently shows $23. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing NOV with unrelated industries.